318 results on '"Sirera R"'
Search Results
52. 9131 POSTER Relative Expression of Regulatory T-lymphocyte Associated Markers Inperipheral Blood Samples From Advanced NSCLC – Analysis of the Prognostic Role
53. 9130 POSTER The Prognostic Role of Myeloid-derived Suppressor Cells Related Markers in Peripheral Blood From Advanced Non-small Cell Lung Cancer Patients
54. 1096 POSTER Expression of Treg Associated Markers Have Prognostic Implications in Early-stage NSCLC
55. Association of Foxp3 expression with prognosis in resected non-small cell lung cancer (NSCLC).
56. Prognostic implications of lymphangiogenic markers in early-stage NSCLC.
57. The surfactant protein B (SFTPB) as a surrogate of circulating tumor cells (CTC) with prognostic value in advanced-stage NSCLC.
58. Metal complexes with N-methyldiethanolamine as new photosensitive precursors for the low-temperature preparation of ferroelectric thin films
59. Plasma levels of VEGF-A and VEGFR-2 in advanced NSCLC.
60. Markers associated with circulating endothelial cells (CEC) in advanced NSCLC: Prognostic value.
61. Expression of angiogenic genes in tumor and stroma as biomarkers of prognosis in NSCLC.
62. Analysis of the prognostic role of regulatory T-lymphocyte-associated marker expression in resectable NSCLC.
63. Improvement of the properties of CSD-processed (Pb0.76Ca0.24)TiO3 thin films by control of the solution chemistry
64. 1087 Expression of angiogenic genes: prognostic marker in patients with early-stage non-small cell lung cancer (NSCLC)
65. 1088 Serum levels of vascular endothelial growth factor receptor 2 (VEGFR2): prognostic biomarker in advanced non-small cell lung cancer (NSCLC)?
66. Expression of angiogenic mediators in head and neck cancer
67. Investigation of infiltrating regulatory T lymphocytes in tumor areas in oral cancer lesions
68. Soluble vascular endothelial growth factor receptor 2 (VEGFR2): New biomarker in advanced non-small cell lung cancer (NSCLC)?
69. Expression of angiogenic genes in resectable non-small cell lung cancer (NSCLC)
70. Pemetrexed as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Efficacy and correlation with molecular markers
71. Prognostic role of serum levels of hTERT, VEGF, and EGFR in metastatic colorectal cancer
72. Plasma quantification of leptin and ubiquitin in patients with advanced non-small cell lung cancer: Correlation with progression and nutritional status
73. 6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?
74. 6591 POSTER Analysis of the progostic value of the quantification of plasmatic epidermal growth factor receptor (EGFR) in advanced non-small cell lung cancer (NSCLC) patients
75. 6611 POSTER Determination of the prognostic value blood levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in advanced non-small cell lung cancer (NSCLC) patients
76. 6569 POSTER The quantification of plasmatic free DNA is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
77. 6592 POSTER Determination of plasma K-ras mutations in codon 12 in advanced non-small cell lung cancer (NSCLC) patients. Analysis of its prognostic role
78. Analysis of the prognostic role of plasmatic K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients
79. The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
80. Effects of the Sol-Gel Processing and Sol Aging on the Properties of the High-Ca Modified PbTiO3Derived Films
81. The quantification of the catalytic subunit of telomerase in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
82. Prognostic value of blood levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in advanced non-small cell lung cancer (NSCLC) patients
83. Analysis of nerve growth factor (NGF) blood levels in patients with advanced non-small cell lung cancer patients (NSCLC): Its correlation with clinical outcome
84. Study of the mechanical behavior of masonry repair lime-based mortars cured and exposed under different conditions
85. P-761 Is anemia a prognostic factor in small cell lung carcinoma (SCLC)?
86. P-465 Efficacy and toxicity of weekly paclitaxel as second/third linechemotherapy for advanced non-small cell lung cancer (NSCLC)
87. PD-004 Serum levels of vascular endothelial growth factor andepidermal growth factor receptor in advanced non-small cell lung cancer: Its correlation with clinical characteristics
88. 4 Neoadjuvant chemotherapy and chemoradiotherapy for locally advanced non small cell lung cancer (NSCLC)
89. PD-026 The analysis of serum DNA concentration by means of hTERT quantification: A useful prognostic factor in advanced non-small cell lung cancer (NSCLC)
90. P-114 C-kit expression in small cell lung cancer (SCLC) patients:Clinical implications
91. P-791 Topotecan every 28 days in refractory or relapsed small cell lungcancer
92. P-466 Sequential (S) chemotherapy (Ch) with gemcitabine (GEM) andpaclitaxel (T) in advanced non-small cell lung cancer (NSCLC): A feasibility phase II study by the Spanish Lung Cancer Group (SLCG). Preliminary study
93. Correlation of blood levels of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor and hemoglobin with response to therapy in advanced non-small cell lung cancer patients (NSCLC)
94. Analysis of the clinical implications of c-kit expression in small cell lung cancer patients (SCLC)
95. The quantification of DNA in the serum is a useful prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
96. 349 Obese subjects with heart failure have low IL-10 plasma levels
97. 186 Soluble TNF-alpha receptor type II levels are elevated in subjects with heart failure and hypertension
98. Genetic heterogeneity in immunogenic epitopes of the hepatitis C virus NS3 protein in liver transplant recipients with recurrent hepatitis C
99. Silicate formation at the interface of a calcium-modified lead titanate thin film deposited on Si(100)
100. Processing Effects on the Compositional Depth Profile of Ferroelectric Sol−Gel Ca−PbTiO3 Thin Films
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.